232 related articles for article (PubMed ID: 25523513)
1. Biomarkers for cardiovascular risk assessment in autoimmune diseases.
Teixeira PC; Ferber P; Vuilleumier N; Cutler P
Proteomics Clin Appl; 2015 Feb; 9(1-2):48-57. PubMed ID: 25523513
[TBL] [Abstract][Full Text] [Related]
2. Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: Genomics and proteomics approaches.
López-Pedrera C; Barbarroja N; Villalba JM
Proteomics Clin Appl; 2009 Feb; 3(2):213-25. PubMed ID: 26238620
[TBL] [Abstract][Full Text] [Related]
3. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.
López-Pedrera C; Barbarroja N; Aguirre MA; Torres LA; Velasco F; Cuadrado MJ
Lupus; 2008 Oct; 17(10):904-15. PubMed ID: 18827055
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular involvement in systemic autoimmune diseases.
Sitia S; Atzeni F; Sarzi-Puttini P; Di Bello V; Tomasoni L; Delfino L; Antonini-Canterin F; Di Salvo G; De Gennaro Colonna V; La Carrubba S; Carerj S; Turiel M
Autoimmun Rev; 2009 Feb; 8(4):281-6. PubMed ID: 18817899
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular risk in autoimmune and inflammatory disorders].
Peeters MA; Chizzolini C
Rev Med Suisse; 2011 Apr; 7(291):867-71. PubMed ID: 21598728
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.
Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Torres-Granados C; Aguirre-Zamorano MA; Collantes-Estevez E; Pérez-Sánchez C
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188016
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do.
Szekanecz Z; Kerekes G; Végh E; Kardos Z; Baráth Z; Tamási L; Shoenfeld Y
Autoimmun Rev; 2016 Jul; 15(7):756-69. PubMed ID: 26979271
[TBL] [Abstract][Full Text] [Related]
8. Proteomic biomarkers for autoimmune disease.
Hueber W; Robinson WH
Proteomics; 2006 Jul; 6(14):4100-5. PubMed ID: 16786488
[TBL] [Abstract][Full Text] [Related]
9. Targeting CVD risk in chronic connective tissue disease.
Malaviya AP; Hall FC
Practitioner; 2012 Jan; 256(1747):21-6, 3. PubMed ID: 22720456
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease biomarkers across autoimmune diseases.
Ahearn J; Shields KJ; Liu CC; Manzi S
Clin Immunol; 2015 Nov; 161(1):59-63. PubMed ID: 26168705
[TBL] [Abstract][Full Text] [Related]
11. Proteomic toolbox for autoimmunity research.
Wu T; Mohan C
Autoimmun Rev; 2009 Jun; 8(7):595-8. PubMed ID: 19393208
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for cardiovascular disease: challenges and future directions.
May A; Wang TJ
Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
[TBL] [Abstract][Full Text] [Related]
13. [The role of proteomics in prognosis and treatment of cardiovascular diseases].
Zuk N; Dubis J; Witkiewicz W
Przegl Lek; 2013; 70(3):143-8. PubMed ID: 24003669
[TBL] [Abstract][Full Text] [Related]
14. Proteome analysis of biological fluids from autoimmune-rheumatological disorders.
De Franceschi L; Bosello S; Scambi C; Biasi D; De Santis M; Caramaschi P; Peluso G; La Verde V; Bambara LM; Ferraccioli G
Proteomics Clin Appl; 2011 Feb; 5(1-2):78-89. PubMed ID: 21246742
[TBL] [Abstract][Full Text] [Related]
15. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
Krintus M; Kozinski M; Kubica J; Sypniewska G
Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
[TBL] [Abstract][Full Text] [Related]
16. Use of proteomics in analysis of autoimmune diseases.
Xiang Y; Kato T
Lupus; 2006; 15(7):431-5. PubMed ID: 16898178
[TBL] [Abstract][Full Text] [Related]
17. Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?
Berezin AE
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S201-S208. PubMed ID: 28011232
[TBL] [Abstract][Full Text] [Related]
18. Where the immune response meets the vessel wall.
Bisoendial RJ; Stroes ES; Tak PP
Neth J Med; 2009 Sep; 67(8):328-33. PubMed ID: 19767659
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis in patients with autoimmune disorders.
Frostegård J
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1776-85. PubMed ID: 15976324
[TBL] [Abstract][Full Text] [Related]
20. Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.
Percy AJ; Byrns S; Chambers AG; Borchers CH
Expert Rev Proteomics; 2013 Dec; 10(6):567-78. PubMed ID: 24206229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
